
Women’s health clinical trials: breaking down barriers through decentralisation
Women tend to be harder to recruit for clinical trials due to socioeconomic factors. But decentralised study designs help ease…
ByWomen tend to be harder to recruit for clinical trials due to socioeconomic factors. But decentralised study designs help ease…
ByFindings indicate nearly 80% of participants in the mavacamten study group no longer needed surgical intervention after the 16-week period.
ByWe spoke to four leaders harnessing AI in clinical trials about its challenges and their vision for AI in the…
ByInnovation Fund Denmark invests in high-risk, high-potential innovation to improve the lives of the Danish population.
ByLifeology is harnessing the art of visual storytelling to help fight mistrust and misinformation in the age of the ‘infodemic.’
ByHealth policy professor Dr Huseyin Naci discusses the risks of leaning too hard on surrogate endpoints in clinical research.
ByNIMH’s Dr Elizabeth Ballard discusses how ketamine has laid the groundwork for a new paradigm of suicide research.
ByA cure for Type 1 diabetes has come one step closer as Vertex reports 90-day results for its synthetic insulin…
ByThank you for subscribing to Clinical Trials Arena